Your Thyroid Numbers Look Normal, Yet You Feel Hypothyroid. Here's Why.

DIO2 is the enzyme responsible for converting T4 into T3 in your tissues. This is the critical step that turns stored thyroid hormone into the active form your cells actually use. Without functional DIO2, T4 sits in your bloodstream doing almost nothing. Your tissues remain starved for active thyroid hormone even though your labs look normal.

The DIO2 Thr92Ala variant (rs225014), carried by roughly 12-15% of the population, reduces the enzyme’s ability to perform this conversion. People with the Ala/Ala genotype may convert T4 to T3 at only a fraction of the rate required for normal metabolism. Your body compensates by trying to produce more T4, but the conversion bottleneck remains. The net result is tissue-level hypothyroidism despite normal circulating T4.

You experience this as persistent fatigue that doesn’t improve with sleep, a metabolism that feels stuck even on a calorie deficit, body temperature that runs cold, brain fog despite adequate sleep, and sometimes depression or anxiety that doesn’t respond to standard treatment. Your cells are literally running on fumes because they can’t access the active thyroid hormone they need.

MTHFR controls the methylation cycle, the process your body uses to activate B vitamins and regulate hundreds of downstream processes, including immune response and thyroid antibody production. When MTHFR is functioning properly, it keeps thyroid-specific antibody levels in check. When it’s impaired, your immune system can become overactive against your own thyroid, accelerating tissue damage and worsening the conversion problem.

The MTHFR C677T variant, carried by roughly 40% of people with European ancestry, reduces methylation enzyme activity by 30-50%. This impairment prevents proper activation of folate and B12, disrupting methylation and allowing thyroid antibodies to rise even if you don’t have diagnosed Hashimoto’s. Additionally, selenium-dependent thyroid peroxidase (the enzyme that synthesizes thyroid hormone) relies on methylation to function optimally. A compromised methylation cycle means impaired thyroid synthesis and elevated antibodies simultaneously.

You experience this as thyroid dysfunction that seems to worsen over time, sometimes accompanied by brain fog from B vitamin deficiency, elevated thyroid antibodies even on a gluten-free diet, and difficulty losing weight despite calorie restriction. The fatigue and cold intolerance from reverse T3 dominance can be compounded by reduced B vitamin function.

VDR controls how effectively your cells absorb and use vitamin D. This matters far beyond bone health. Vitamin D is a hormone, not just a nutrient, and it directly regulates deiodinase enzymes (including DIO2, the T4-to-T3 converter). When VDR function is impaired, your cells can’t access vitamin D efficiently, even if you’re supplementing or spending time in the sun. The deiodinases that depend on vitamin D signaling become underactive, and T4-to-T3 conversion stalls.

The VDR BsmI, FokI, and TaqI variants are carried by roughly 30-50% of the population. These variants reduce cellular vitamin D uptake, meaning you may remain functionally deficient in vitamin D despite supplementation or normal serum levels. Your cells simply cannot use the vitamin D circulating in your blood efficiently. When vitamin D signaling is weak, DIO2 becomes less active, and reverse T3 dominance worsens.

You experience this as persistent vitamin D deficiency despite supplementation, thyroid dysfunction that doesn’t improve despite normal T4 and TSH, increased infection susceptibility, weak immune response, and a metabolic rate that feels permanently depressed. Cold intolerance and fatigue from reverse T3 are often worse in people with VDR variants because the genetic block to vitamin D means the block to T4 conversion is compounded.

GC encodes the vitamin D binding protein (VDBP), which transports vitamin D throughout your bloodstream. This seems straightforward, but VDBP variants create a critical problem: they affect how much vitamin D remains free (available to your cells) versus bound (circulating but locked in the VDBP molecule). Some GC haplotypes bind vitamin D too tightly, leaving less available to tissues. This is particularly relevant for thyroid conversion because bioavailable vitamin D is what activates the deiodinases.

GC variants are common across all populations, with three main haplotypes (1s, 1f, 2) affecting VDBP function and vitamin D binding affinity. Carriers of certain GC haplotypes may have less free, bioavailable vitamin D despite normal or even elevated total vitamin D levels. Standard vitamin D testing measures total vitamin D (bound plus free), so you can appear replete while your tissues actually remain deficient. This impairs DIO2 function and perpetuates reverse T3 dominance.

You experience this as paradoxically low thyroid conversion despite supplementing vitamin D and having normal or high serum vitamin D levels on paper. Your doctor sees your vitamin D is 60 ng/mL and wonders why you still feel cold and fatigued. The answer is that most of that vitamin D is bound and unavailable to your thyroid conversion machinery.

HFE regulates hepcidin, the hormone that controls iron absorption and recycling. Iron is essential for thyroid peroxidase, the enzyme that manufactures thyroid hormone in the first place. When HFE variants cause iron dysregulation, either too much iron (which causes oxidative stress) or too little (which impairs thyroid hormone synthesis), the entire thyroid pathway suffers. Additionally, excess iron drives the conversion of T4 into reverse T3 instead of active T3. The body does this as a protective mechanism, slowing metabolism when iron is elevated and causing cellular damage.

The HFE H63D variant, carried by roughly 15-20% of people with European ancestry, is associated with mild iron dysregulation. While not as severe as C282Y homozygosity (true hemochromatosis), H63D still impairs fine-tuned iron regulation, often leading to either iron accumulation or iron deficiency depending on diet and other factors. When iron is elevated, deiodinase enzymes shift toward producing reverse T3 as a metabolic brake. When iron is deficient, thyroid hormone synthesis itself declines.

You experience this as thyroid dysfunction that doesn’t improve despite proper supplementation, sometimes with puzzling iron levels on bloodwork (either too high or too low), unexplained fatigue beyond what reverse T3 would cause alone, and sometimes joint pain or mood changes if iron is elevated. The mismatch between your thyroid treatment and your recovery is often a sign that iron balance needs addressing.

BCMO1 controls the conversion of plant-based beta-carotene (from vegetables) into usable retinol (active vitamin A). Vitamin A is a hormone, not just a nutrient, and it’s essential for thyroid hormone receptor function. Your cells cannot properly respond to T3 without adequate intracellular vitamin A. Additionally, BCMO1 variants mean you’re less able to extract vitamin A from the colorful vegetables you eat, leaving you functionally deficient despite seemingly adequate intake.

The BCMO1 R267S and A379V variants are carried by roughly 45% of the population. People with these variants convert beta-carotene to retinol at roughly half the rate of those without them, requiring preformed vitamin A from animal sources to maintain tissue adequacy. Even if your serum vitamin A levels appear normal, your cells may not have enough to support thyroid hormone receptor signaling. This means even if DIO2 and other genes are functioning well and you’re producing active T3, your cells can’t fully respond to it.

You experience this as persistent thyroid symptoms despite good T4-to-T3 conversion, sometimes with additional signs of vitamin A deficiency (poor night vision, dry skin, infections). The fatigue and cold intolerance from reverse T3 can be worsened if your cells simultaneously can’t respond adequately to the T3 you are producing. Thyroid medication may help less than expected if the vitamin A piece is missing.